133 related articles for article (PubMed ID: 32155332)
1. Impaired O-Glycosylation at Consecutive Threonine TTX Motifs in Mucins Generates Conformationally Restricted Cancer Neoepitopes.
Hayakawa S; Matsushita T; Yokoi Y; Wakui H; Garcia-Martin F; Hinou H; Matsuoka K; Nouso K; Kamiyama T; Taketomi A; Nishimura SI
Biochemistry; 2020 Mar; 59(12):1221-1241. PubMed ID: 32155332
[TBL] [Abstract][Full Text] [Related]
2. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
3. Order and maximum incorporation of N-acetyl-D-galactosamine into threonine residues of MUC2 core peptide with microsome fraction of human-colon-carcinoma LS174T cells.
Iida S; Takeuchi H; Kato K; Yamamoto K; Irimura T
Biochem J; 2000 Apr; 347(Pt 2):535-42. PubMed ID: 10749684
[TBL] [Abstract][Full Text] [Related]
4. Roles of the gel-forming MUC2 mucin and its O-glycosylation in the protection against colitis and colorectal cancer.
Kawashima H
Biol Pharm Bull; 2012; 35(10):1637-41. PubMed ID: 23037153
[TBL] [Abstract][Full Text] [Related]
5. O-glycosylated MUC2 monomer and dimer from LS 174T cells are water-soluble, whereas larger MUC2 species formed early during biosynthesis are insoluble and contain nonreducible intermolecular bonds.
Axelsson MA; Asker N; Hansson GC
J Biol Chem; 1998 Jul; 273(30):18864-70. PubMed ID: 9668062
[TBL] [Abstract][Full Text] [Related]
6. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
[TBL] [Abstract][Full Text] [Related]
8. High density O-glycosylation of the MUC2 tandem repeat unit by N-acetylgalactosaminyltransferase-3 in colonic adenocarcinoma extracts.
Inoue M; Takahashi S; Yamashina I; Kaibori M; Okumura T; Kamiyama Y; Vichier-Guerre S; Cantacuzène D; Nakada H
Cancer Res; 2001 Feb; 61(3):950-6. PubMed ID: 11221889
[TBL] [Abstract][Full Text] [Related]
9. Seromic profiling of colorectal cancer patients with novel glycopeptide microarray.
Pedersen JW; Blixt O; Bennett EP; Tarp MA; Dar I; Mandel U; Poulsen SS; Pedersen AE; Rasmussen S; Jess P; Clausen H; Wandall HH
Int J Cancer; 2011 Apr; 128(8):1860-71. PubMed ID: 21344374
[TBL] [Abstract][Full Text] [Related]
10. Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer.
Jiang Y; Liu Z; Xu F; Dong X; Cheng Y; Hu Y; Gao T; Liu J; Yang L; Jia X; Qian H; Wen T; An G
J Cell Mol Med; 2018 Oct; 22(10):4875-4885. PubMed ID: 29999571
[TBL] [Abstract][Full Text] [Related]
11. Dimerization of the human MUC2 mucin in the endoplasmic reticulum is followed by a N-glycosylation-dependent transfer of the mono- and dimers to the Golgi apparatus.
Asker N; Axelsson MA; Olofsson SO; Hansson GC
J Biol Chem; 1998 Jul; 273(30):18857-63. PubMed ID: 9668061
[TBL] [Abstract][Full Text] [Related]
12. Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides.
Liu X; Sejbal J; Kotovych G; Koganty RR; Reddish MA; Jackson L; Gandhi SS; Mendonca AJ; Longenecker BM
Glycoconj J; 1995 Oct; 12(5):607-17. PubMed ID: 8595249
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
Hanisch FG; Stadie T; Bosslet K
Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
[TBL] [Abstract][Full Text] [Related]
14. The Densely O-Glycosylated MUC2 Mucin Protects the Intestine and Provides Food for the Commensal Bacteria.
Arike L; Hansson GC
J Mol Biol; 2016 Aug; 428(16):3221-3229. PubMed ID: 26880333
[TBL] [Abstract][Full Text] [Related]
15. Early steps in the biosynthesis of MUC2 epithelial mucin in colon cancer cells.
McGuckin MA; Devine PL; Ward BG
Biochem Cell Biol; 1996; 74(1):87-93. PubMed ID: 9035693
[TBL] [Abstract][Full Text] [Related]
16. Alkali-catalyzed beta-elimination of periodate-oxidized glycans: a novel method of chemical deglycosylation of mucin gene products in paraffin embedded sections.
Hong JC; Kim YS
Glycoconj J; 2000 Oct; 17(10):691-703. PubMed ID: 11425189
[TBL] [Abstract][Full Text] [Related]
17. Production of monoclonal antibodies recognising the peptide core of MUC2 intestinal mucin.
Durrant LG; Jacobs E; Price MR
Eur J Cancer; 1994; 30A(3):355-63. PubMed ID: 8204359
[TBL] [Abstract][Full Text] [Related]
18. In vivo glycosylation of mucin tandem repeats.
Silverman HS; Parry S; Sutton-Smith M; Burdick MD; McDermott K; Reid CJ; Batra SK; Morris HR; Hollingsworth MA; Dell A; Harris A
Glycobiology; 2001 Jun; 11(6):459-71. PubMed ID: 11445551
[TBL] [Abstract][Full Text] [Related]
19. O-glycosylated human MUC1 repeats are processed in vitro by immunoproteasomes.
Ninkovic T; Hanisch FG
J Immunol; 2007 Aug; 179(4):2380-8. PubMed ID: 17675499
[TBL] [Abstract][Full Text] [Related]
20. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
